nVerses Capital’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20,286
Closed -$63.1K – 45
2026
Q2
$63.1K Buy
+20,286
New +$66.7K 0.1% 261
2024
Q4
– Sell
-3,000
Closed -$14.2K – 134
2024
Q3
$14.2K Buy
+3,000
New +$17.4K 0.01% 852

Other funds holding CABA

nVerses Capital's CABA Position: Q3 2026 in Review

nVerses Capital sold out of Cabaletta Bio (CABA) in Q3 2026, closing a stake of 20,286 shares — an estimated $63.1K sold.

nVerses Capital first reported a position in CABA in Q3 2024 and held it in 2 quarters. The position peaked at $63.1K in Q2 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • nVerses Capital reported no remaining Cabaletta Bio position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 20,286 Cabaletta Bio shares in Q3 2026, an estimated $63.1K.
  • nVerses Capital first reported a position in Cabaletta Bio in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's Cabaletta Bio position peaked at $63.1K in Q2 2026.
  • 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.